WMJ Vol 120 Supplement 1: Homicide: A Leading Cause of Death for Black Non-Hispanics in Wisconsin

ABSTRACT

Importance: Wisconsin has the second-highest Black homicide rate in the country, reporting a rate of 37.57 deaths per 100,000 Black non-Hispanic Wisconsinites. Meanwhile, White non-Hispanics experience a homicide rate of 2.0 deaths per 100,000.

Objective: This data identifies a public health disparity that deserves further investigation. This study seeks to detail the mortality rate of all-cause homicide, firearm-related homicide, non-firearm-related homicide, and legal intervention firearm-related homicide; leading causes of death; average age of death; and years of potential life lost (YPLL) between White non-Hispanics and Black non-Hispanics in Wisconsin during 2000-2017.

Design: Wisconsin homicide rates, ranked leading causes of death, and average age of death were obtained through the Wisconsin Department of Health Services via the Wisconsin Interactive Statistics on Health (WISH) Query System. National data were obtained through the Centers for Disease Control and Prevention’s Web-based Injury Statistics Query and Reporting System (WISQARS). Homicide rates, ranked leading causes of death, average age of death, and YPLL were compared by mechanism of injury, county of residence, and race and ethnicity.

Participants and Exposures: The entire population of Black non-Hispanic Americans and White non-Hispanic Americans during 2000-2017 was included. For comparison, this was narrowed to the population of Black non-Hispanic Wisconsinites and White non-Hispanic Wisconsinites during 2000-2017. Exposure groups include all homicide victims during 2000-2017.

Main Outcomes and Measures: We hypothesized that Black non-Hispanic Wisconsinites would have a significantly worse burden of disease compared to White non-Hispanic Wisconsinites, as well as Black non-Hispanic Americans.

Results: This study found that firearm-related homicide rates for Black non-Hispanics compared to White non-Hispanics were 14.6 times greater in Milwaukee, 29.9 times greater in Wisconsin, and 13.0 times greater in urban counties of the United States. Firearm-related homicide is the second-leading cause of death for Black non-Hispanics in Milwaukee and the fourth-leading cause of death in Wisconsin. YPLL per person for Black non-Hispanic victims of firearm-related homicide are 36.83 years in Milwaukee and 37.04 years in Wisconsin.

Conclusion and Relevance: Our findings strongly suggest that Black non-Hispanic Wisconsinites endure a significantly worse burden of firearm-related homicide compared to White non-Hispanic Wisconsinites and Black non-Hispanic Americans. This study demonstrates a significant disparity in firearm-related homicide that should inspire policy discussion.

Intended Audience

The target audience for this journal-based activity is healthcare providers caring for the people and communities of Wisconsin and beyond.

Learning Objectives

As a result of this journal-based activity, the healthcare team will be able to:

  1. Explain the extent to which racial disparities impact homicide victims in Wisconsin.
  2. Summarize the burden of disease and years of potential life lost in firearm-related homicide.
  3. Identify the impact of the racial disparity of firearm-related deaths during legal intervention in Wisconsin.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™
Registration opens: 
05/03/2021
Course expires: 
12/31/2021
Cost:
$0.00
Rating: 
0

FACULTY DISCLOSURE

It is the policy of the University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP) to identify, mitigate and disclose all relevant financial relationships with ineligible companies* held by the  speakers/presenters, authors, planners, and other persons who may influence content of this accredited continuing education (CE).  In addition, speakers, presenters and authors must disclose any planned discussion of unlabeled/unapproved uses of drugs or devices during their presentation.

For this accredited continuing education activity all relevant financial relationships have been mitigated and detailed disclosures are listed below.

Name of IndividualIndividual's Role in Activity

Name of Commercial Interest &
Nature of Relationship

Discussion of
Unlabeled/Unapproved
Uses of Drugs/Devices
in Presentation?

Terese Bailey, BSAccreditation SpecialistNo relevant relationships with ineligible companies to discloseNo
Zachary Dunton, BSAuthorNo relevant relationships with ineligible companies to discloseNo
David Dwyer, PhD, RN, NE-BCReviewerNo relevant relationships with ineligible companies to discloseNo
Ronald Gangnon, PhDReviewerNo relevant relationships with ineligible companies to discloseNo
Stephen Hargarten, MD, MPHAuthorNo relevant relationships with ineligible companies to discloseNo

Sarah Kohlbeck, MPH

Author

No relevant relationships with ineligible companies to disclose

No

Fauzia Osman, MPH

Author

No relevant relationships with ineligible companies to disclose

No

Elaine M. Pelley, MDReviewerNo relevant relationships with ineligible companies to discloseNo
Elizabeth M. Petty, MDReviewerNo relevant relationships with ineligible companies to discloseNo

Robert Treat, PhD

Editor

No relevant relationships with ineligible companies to disclose

No

*Ineligible companies are those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on, patients.

The ACCME does not consider providers of clinical services directly to patients to be commercial interests.

Discloser List CME Internal Report

Accreditation

Accreditation Statement

Jointly Accredited Provider LogoIn support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Wisconsin Medical Journal.  The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credit Designation Statements

American Medical Association (AMA)

The University of Wisconsin–Madison ICEP designates this journal-based CE activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Education Units

The University of Wisconsin–Madison ICEP, as a member of the University Professional & Continuing Education Association (UPCEA), authorizes this program for 0.1 continuing education units (CEUs) or 1 hour.

Available Credit

  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Free, current version of Chrome, Firefox, Safari, or Edge. Some older browsers and Microsoft Internet Explorer could produce error messages or not display the content correctly. 

Free, current version of Adobe Acrobat Reader or other .pdf reader.